Education
About Us
Working with TipRanks
Follow Us
Danaher Corporation (DHR)
:DHR
DHR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$171.00 - $279.90
Previous CloseN/A
Volume816.38K
Average Volume (3M)4.21M
Market Cap
$147.69B
Enterprise Value$158.56B
Total Cash (Recent Filing)$2.96B
Total Debt (Recent Filing)$18.55B
Price to Earnings (P/E)44.1
Beta0.92
Next Earnings
Oct 28, 2025EPS Estimate
1.72Last Dividend Ex-Date
Jun 27, 2025Dividend Yield0.57%
Share Statistics
EPS (TTM)1.80
Shares Outstanding716,051,600
10 Day Avg. Volume3,145,457
30 Day Avg. Volume4,205,444
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue6.60
Enterprise Value/Gross Profit10.73
Enterprise Value/Ebitda23.47
Forecast
1Y Price Target
$238.13Price Target Upside15.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
Bulls Say, Bears Say
Bulls Say
EarningsDanaher reported second-quarter results that were largely in line with to better than expectations, including a slight beat on the top line and a healthy EPS beat on the bottom line.
Financial GuidanceDHR has raised the EPS guide on the back of more favorable FX and benefit from cost actions.
Recurring RevenueDHR is seen as the leader in the highly attractive, recurring revenue market of bioprocess tools.
Bears Say
DemandWeaker demand and uncertain end-market conditions in biotech and academia offset the encouraging strength in bioprocessing.
Market ConditionsThere are still headwinds, including weak US markets and a downturn in China.
Danaher News
DHR FAQ
What was Danaher Corporation’s price range in the past 12 months?
Danaher Corporation lowest stock price was $171.00 and its highest was $279.90 in the past 12 months.
What is Danaher Corporation’s market cap?
Danaher Corporation’s market cap is $147.69B.
When is Danaher Corporation’s upcoming earnings report date?
Danaher Corporation’s upcoming earnings report date is Oct 28, 2025 which is in 61 days.
How were Danaher Corporation’s earnings last quarter?
Danaher Corporation released its earnings results on Jul 22, 2025. The company reported $1.8 earnings per share for the quarter, beating the consensus estimate of $1.643 by $0.157.
Is Danaher Corporation overvalued?
According to Wall Street analysts Danaher Corporation’s price is currently Undervalued.
Does Danaher Corporation pay dividends?
Danaher Corporation pays a Quarterly dividend of $0.32 which represents an annual dividend yield of 0.57%. See more information on Danaher Corporation dividends here
What is Danaher Corporation’s EPS estimate?
Danaher Corporation’s EPS estimate is 1.72.
How many shares outstanding does Danaher Corporation have?
Danaher Corporation has 716,051,600 shares outstanding.
What happened to Danaher Corporation’s price movement after its last earnings report?
Danaher Corporation reported an EPS of $1.8 in its last earnings report, beating expectations of $1.643. Following the earnings report the stock price went up 0.978%.
Which hedge fund is a major shareholder of Danaher Corporation?
Currently, no hedge funds are holding shares in DHR
Danaher Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$238.13 (15.46% Upside)
$238.13 (15.46% Upside)
Blogger Sentiment
Bullish
DHR Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 6.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $586.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.65%
12-Months-Change
Fundamentals
Return on Equity
6.68%
Trailing 12-Months
Asset Growth
3.90%
Trailing 12-Months
Company Description
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
DHR Company Deck
DHR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a generally positive outlook with strong growth in the bioprocessing segment and solid financial performance, despite challenges in the life sciences segment and the China market, as well as uncertainties due to global trade tensions.View all DHR earnings summariesDHR Revenue Breakdown
40.99% Diagnostics
30.70% Life Sciences
28.31% Biotechnology
DHR Stock 12 Month Forecast
Average Price Target
$238.13
▲(15.46% Upside)
Technical Analysis
Ownership Overview
8.78% Insiders
25.45% Mutual Funds
15.85% Other Institutional Investors
30.98% Public Companies and Individual Investors